Les thérapies ciblées (Oncologie pratique) Coll. Oncologie pratique
Langue : Français
Auteurs : BLAY Jean-Yves, GUETZ Gaëtan Des, MORÈRE Jean-François
En 2008, les progrès des connaissances en matière de carcinogenèse ont
permis d'identifier des cibles moléculaires clés dans la genèse de
nombreuses tumeurs solides. Bien que non exhaustives encore, ces
informations permettent l'utilisation de composés dirigés contre les
cibles moléculaires, spécifiquement activées dans les cancers donnant
ainsi naissance au concept de thérapie ciblée. Plusieurs anticorps sont
déjà commercialisés, dirigés contre des cytokines ou des récepteurs, de
même 6 molécules inhibitrices de tyrosine kinases sont actuellement
commercialisées ou en voie de l'être. Ces traitements donnent parfois des
taux de réponse limités en monothérapie, mais ont souvent une activité
antitumorale additive avec la chimiothérapie dans plusieurs types de
tumeurs. Nous ne sommes qu'au début du développement prometteur de ces
nouvelles classes thérapeutiques, visant de nouvelles cibles moléculaires
(EGFR, VEGF, IGFR, Rank...). Un ouvrage pratique s'imposait pour faire le
point sur l'utilisation courante de ces nouvelles molécules.
Opening lecture. Sudden Death Prevention in Heart Failure: Which Role for
ICD? In-and outhospital management of heart failure patients.
ACE-Inhibitors, Blockers, Spironolactone: Do We Need Many More Drugs to
Treat Chronic Heart Failure? Non-Invasive Evaluation and Early Treatment
of Heart Failure Patients. The Problem of Recreational Sport in Patients
with Mild to Moderate Heart Failure. Wireless Home Monitoring in Permanent
Cardiac Stimulation: is it Especially Suitable in CHF Patients?
Organisational and Economical Point of View in the Management of
Congestive Heart Failure Patient. Electromagnetic Interferences in
Biventricular and/or ICD Paced Patients. Atrial Arrhythmias: Drugs,
Devices or Ablation. Atrial Fibrillation and Flutter: Sympathetic Nervous
System and Arrhythmogenesis. Current approach and treatment in acute
atrial fibrillation. Pacing, ICD, or Both for the Hybrid Therapy of Atrial
Arrhythmias? Is There Still a Role for Right Atrial Ablation in Patients
with Atrial Fibrillation? Multidisciplinary Approach to Heart Failure and
Cardiac Resynchronization Therapy. The Selection of Patients for Cardiac
Resynchronization Therapy. The Perspective of the Emergency Department.
Ventricular Pacing in CHF: The Role of the Internist. Atrial Fibrillation
and Heart Failure: the Chicken-egg Dilemma. Type of Therapy and Quality of
Life in Atrial Fibrillation. Ablation of Atrial Fibrillation in Chronic
Heart Failure Patient: Facts or Fancy. Risk-Stratification in Heart
Failure Patients with Varying Disease Severity. Atrial Fibrillation
Therapy: From Fiction to Facts. Cardioversion of Recent-Onset Paroxysmal
Atrial Fibrillation to Sinus Rhythm in the Emergency Department:
Comparison of Intravenous Drugs. The Present Role And Future Perspectives
Of Radiofrequency Ablation Of Atrial Fibrillation. The Affirm Study and
Its Implications for the Pharmacological Treatment of AF. Antiarrhythmic
Agents in Atrial Fibrillation: A New Role in the Context of a Hybrid
Approach? State of the Art in the Current Trends and Treatments of Atrial
Fibrillation and Flutter.- Atrial Fibrillation: New Insights Into
Electrophysiologic Mechanisms. Pharmacological therapy of atrial
fibrillation and flutter: advances and limitations of specific
antiarrhythmic drugs. Atrial Fibrillation and Flutter: the Latest from the
Planet of Right RF Catheter Ablation. Hot Topics in Tachyarrhythmias
management.- Impact of LocaLisa on Ablation Management. Device Therapy for
Atrial Arrhythmias: Latest Topics from the AT500 Italian Registry. The
Role of Electrical Therapy in Patients with Left Ventricular Dysfunction.
Role of Electrical Therapy in Patients with Left Ventricular Dysfunction:
The Clinical Cardiologist's Experience. The Electrophysiological Aspect.
New Approaches in Electrical Treatment and Management of Heart Failure
Patients.-Benefits of Closed Loop Stimulation in Resynchronization
Therapy. Optimization Of Resynchronization Therapy by Intracardiac
Ventricular Impedance. Dual Site Right Ventricular Pacing in Heart Failure
Patients. The role of 'single shock' ICD for sudden death primary
prevention in heart failure patients. Biventricular Pacing: A Simplified
Technique For Transvenous Implantation. Innovative Pacing Techniques:
Solutions for AF and HF. Pacing in Atrial Fibrillation: Therapies for
Rhythm Control.Pacing in Atrial Fibrillation: Therapies for Rate Control.
What Have We Learned from Cardiac Resynchronization Trials? Is There Still
a Role for Cardioversion in AF Patients? Is Fluoroscopic Electrode
Positioning Improving the Clinical Efficacy of External Biphasic
Cardioversion in patients with AF? Is Transesophageal Echocardiography.
Date de parution : 06-2008
Ouvrage de 198 p.
15.5x23.5 cm
Retiré de la vente
61,00 €
Télécharger
Thèmes de Les thérapies ciblées :
© 2024 LAVOISIER S.A.S.